Original Research
Accepted on 03 Nov 2025
Pharmacovigilance study of the frequency of gastrointestinal ulceration reports associated with immune checkpoint inhibitors: insights from the FDA Adverse Event Reporting System
in Gastrointestinal and Hepatic Pharmacology